SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-09-056183
Filing Date
2009-11-02
Accepted
2009-11-02 15:10:21
Documents
1
Effectiveness Date
2009-11-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS c91740defa14a.htm DEFA14A 15741
  Complete submission text file 0000950123-09-056183.txt   17147
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24274 | Film No.: 091150907
SIC: 2836 Biological Products, (No Diagnostic Substances)